Clinical trial Recruiting at 1 site Observational Ages 18 and up

Diagnosing brief stroke-like (TIA) events in the emergency room

Official title: Diagnosis of Transient Ischemic Attacks in the Emergency Department

Run by University Hospital, Strasbourg, France · NCT07339787 · Data updated 2026-11-12

This project will look at how adults who come to the emergency room with a transient ischemic attack (TIA) are managed to see if extra tests, treatments, and referrals match their cardiovascular risk.

More Transient Ischemic Attack trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorUniversity Hospital, Strasbourg, France
Academic / other
Locations1 site (Strasbourg)
StatusRecruiting
StartedFebruary 6, 2025
Main results expectedJanuary 2027
Study endsJanuary 6, 2027
Registry record updatedJanuary 14, 2026
Trial IDNCT07339787 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) who presented to the CHU de Strasbourg emergency department with a transient neurological deficit that had fully resolved by arrival during the study period are eligible.

Probably not a fit

People with persistent neurological deficits consistent with stroke, patients not seen in the CHU de Strasbourg ED during the specified dates, or those with non-TIA diagnoses will not be included and will not directly benefit from this analysis.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective observational review of adults coded with a TIA in the CHU de Strasbourg emergency department between January 1 and December 12, 2024. Researchers will compile ED records via the regional emergency observatory coding to record which additional examinations, treatments, and specialist referrals were performed. The study will compare those management decisions with patients' cardiovascular risk to determine whether care intensity aligns with risk. Findings will describe variability in practice and identify gaps in access to neurovascular expertise, particularly for low-risk versus high-risk patients.

Why it matters

Potential benefit: If patterns show mismatch between risk and care, the results could inform clearer triage and referral pathways so high-risk patients get specialist attention while low-risk patients avoid unnecessary testing.

How similar studies have gone: Other hospitals with dedicated TIA clinics have reported reduced early recurrence and cardiovascular morbidity after implementing rapid-access TIA care, so the model has supporting evidence even though this study focuses on management variability.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult (≥18 years old)
* Having consulted the emergency department or been diagnosed with TIA during the period from January 1, 2024, to December 12, 2024 (records will be compiled via coding at the East Rescue regional emergency observatory)
* TIA will be defined as a sudden, transient neurological deficit that had disappeared by the time of arrival at the emergency department

Exclusion Criteria:

\- Subjects with a suspected diagnosis of TIA, i.e., with a sudden, transient neurological deficit that had disappeared by the time of arrival at the emergency department.

Where it's running

  • Service d'Urgences Médico-Chirurgicales Adules - CHU de Strasbourg - France
    Strasbourg, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.